礼来(LLY):Zepbound在减重效果上胜过诺和诺德(NVO)的Wegovy

金吾财讯
05 Dec 2024

金吾财讯 | 美国大型制药企业礼来(LLY)宣布,在一项对比研究中,其研发的减肥药Zepbound在减重效果上超越了诺和诺德(NVO)的Wegovy。

研究数据显示,服用Zepbound的参与者体重平均下降了20.2%,相比之下,使用Wegovy的参与者体重减轻了13.7%。礼来公司打算将这些研究成果提交至同行评审的学术期刊,并计划在即将举行的医学会议上公布这些数据。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10